{"id":755183,"date":"2023-05-04T16:42:39","date_gmt":"2023-05-04T20:42:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/"},"modified":"2023-05-04T16:42:39","modified_gmt":"2023-05-04T20:42:39","slug":"spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/","title":{"rendered":"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting<\/b><\/p>\n<p class=\"bwalignc\"><i>Mitchell Geffner, M.D., to Present on May 7, 2023 from 12:30 pm \u2013 2 pm PT<\/i><\/p>\n<p>SOUTH SAN FRANCISCO, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sprucebiosciences.com%2F&amp;esheet=53393503&amp;newsitemid=20230504005432&amp;lan=en-US&amp;anchor=Spruce+Biosciences%2C+Inc&amp;index=1&amp;md5=80514b914c04d8decef18cd1252aaa77\">Spruce Biosciences, Inc<\/a>. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for poster presentation at the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpedsendo.org%2Feducation-events%2Fpes-2023-annual-meeting%2F&amp;esheet=53393503&amp;newsitemid=20230504005432&amp;lan=en-US&amp;anchor=Pediatric+Endocrine+Society+%28PES%29+2023+Annual+Meeting&amp;index=2&amp;md5=37636bcc94f2dfcd5338ad6546bd0202\">Pediatric Endocrine Society (PES) 2023 Annual Meeting<\/a> taking place May 5-8, 2023, in San Diego, Calif. Mitchell Geffner, M.D., will present findings on a retrospective analysis of completion rates for adult and pediatric congenital adrenal hyperplasia (CAH) studies.<\/p>\n<p>\nDetails are as follows:<\/p>\n<p><b>Title:<\/b> Clinical Trials in CAH: So Many Starting, but Not So Many Finishing<br \/>\n<br \/><b>Abstract Number:<\/b> 6407<br \/>\n<br \/><b>Poster Session: <\/b>3<br \/>\n<br \/><b>Session Date &amp; Time: <\/b>Sunday, May 7, 2023 from 12:30 pm \u2013 2 pm PT<br \/>\n<br \/><b>Presenter:<\/b> Mitchell E. Geffner, M.D., Co-Director of the Congenital Adrenal Hyperplasia Comprehensive Care Clinic and Professor of Pediatrics, Keck School of Medicine of University of Southern California<br \/>\n<br \/><b>Authors:<\/b> P.J. Ramtin, R. Will Charlton M.D., M.A.S., Mitchell E. Geffner M.D.<\/p>\n<p>\nAccess more information about PES 2023 <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpedsendo.org%2Feducation-events%2Fpes-2023-annual-meeting%2F&amp;esheet=53393503&amp;newsitemid=20230504005432&amp;lan=en-US&amp;anchor=here&amp;index=3&amp;md5=856368388e0e85fafafea520d880f24a\">here<\/a>.<\/p>\n<p><b>About Spruce Biosciences<\/b><\/p>\n<p>\nSpruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Spruce is also developing tildacerfont for women suffering from polycystic ovary syndrome (PCOS) with primary adrenal androgen excess. To learn more, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sprucebiosciences.com&amp;esheet=53393503&amp;newsitemid=20230504005432&amp;lan=en-US&amp;anchor=www.sprucebiosciences.com&amp;index=4&amp;md5=3e36c4aa93e4214cd4f98b18352107fe\">www.sprucebiosciences.com<\/a> and follow us on Twitter @<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fspruce_bio&amp;esheet=53393503&amp;newsitemid=20230504005432&amp;lan=en-US&amp;anchor=Spruce_Bio&amp;index=5&amp;md5=5326f43721064fa0609f4ee878706611\">Spruce_Bio<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fspruce-biosciences%2F&amp;esheet=53393503&amp;newsitemid=20230504005432&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=6&amp;md5=a5025dc955a9e8f86225b2a5c9f35e0b\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FSpruceBio%2F&amp;esheet=53393503&amp;newsitemid=20230504005432&amp;lan=en-US&amp;anchor=Facebook&amp;index=7&amp;md5=12471e53302cde36c756db2b7728a8db\">Facebook<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCiPbmokQUFy9wc3wvY5PZnw&amp;esheet=53393503&amp;newsitemid=20230504005432&amp;lan=en-US&amp;anchor=YouTube&amp;index=8&amp;md5=08b590cad96e901fa0cead94662b81bb\">YouTube<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230504005432\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230504005432\/en\/<\/a><\/span><\/p>\n<p><b>Media<br \/>\n<\/b><br \/>Will Zasadny<br \/>\n<br \/>Evoke Canale<br \/>\n<br \/>(619) 961-8848<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:will.zasadny@evokecanale.com\">will.zasadny@evokecanale.com<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"mailto:media@sprucebiosciences.com\">media@sprucebiosciences.com<\/a><\/p>\n<p><b>Investors<br \/>\n<\/b><br \/>Xuan Yang<br \/>\n<br \/>Solebury Strategic Communications<br \/>\n<br \/>(415) 971-9412<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:xyang@soleburystrat.com\">xyang@soleburystrat.com<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"mailto:investors@sprucebiosciences.com\">investors@sprucebiosciences.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Clinical Trials Research Pharmaceutical Science Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230504005432\/en\/789688\/3\/Picture1.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting Mitchell Geffner, M.D., to Present on May 7, 2023 from 12:30 pm \u2013 2 pm PT SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for poster presentation at the Pediatric Endocrine Society (PES) 2023 Annual Meeting taking place May 5-8, 2023, in San Diego, Calif. Mitchell Geffner, M.D., will present findings on a retrospective analysis of completion rates for adult and pediatric congenital adrenal hyperplasia (CAH) studies. Details are as &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-755183","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting Mitchell Geffner, M.D., to Present on May 7, 2023 from 12:30 pm \u2013 2 pm PT SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for poster presentation at the Pediatric Endocrine Society (PES) 2023 Annual Meeting taking place May 5-8, 2023, in San Diego, Calif. Mitchell Geffner, M.D., will present findings on a retrospective analysis of completion rates for adult and pediatric congenital adrenal hyperplasia (CAH) studies. Details are as &hellip; Continue reading &quot;Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T20:42:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting\",\"datePublished\":\"2023-05-04T20:42:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/\"},\"wordCount\":358,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/\",\"name\":\"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-05-04T20:42:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting - Market Newsdesk","og_description":"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting Mitchell Geffner, M.D., to Present on May 7, 2023 from 12:30 pm \u2013 2 pm PT SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for poster presentation at the Pediatric Endocrine Society (PES) 2023 Annual Meeting taking place May 5-8, 2023, in San Diego, Calif. Mitchell Geffner, M.D., will present findings on a retrospective analysis of completion rates for adult and pediatric congenital adrenal hyperplasia (CAH) studies. Details are as &hellip; Continue reading \"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-04T20:42:39+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting","datePublished":"2023-05-04T20:42:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/"},"wordCount":358,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/","name":"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-05-04T20:42:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230504005432r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spruce-biosciences-to-present-findings-on-retrospective-analysis-of-completion-rates-for-cah-studies-at-pediatric-endocrine-society-2023-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=755183"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755183\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=755183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=755183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=755183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}